Hebei University of Science and Technology in north China said its associate professor Han Chunyu, 42 will "publicly verify" his findings under the supervision of an "authoritative third party" in around a month.
Han published a paper in the May edition of "Nature Biotechnology" describing new genome editing technology NgAgo that could be an alternative to the mainstream CRISPR/Cas9 technique.
With China currently in desperate pursuit of heavyweight scientific achievements, Han became an overnight sensation.
But doubts immediately emerged with other researchers declaring that the results cannot be replicated.
Among them was Dr Gaetan Burgio of the Australian National University.
On Friday, Burgio said in an online article that his laboratory had tried to establish Han's protocol over the last two months, but found "no evidence for genome editing with NgAgo after multiple attempts with various settings and three different genes."
Burgio went on to call for researchers to be more open with their results, rather than to"chase high impact publication and be secretive."
As a condition of publication in any Nature Research journal, authors are required to make all material, data, code and associated protocols promptly available to readers.
Han, however, said scientific achievements should be subject to the tests of time and practice, adding that he is confident his results will be reproduced by other researchers.
In earlier media interviews, he claimed the experiment had been repeated many times in his laboratory.
Han said the skeptics had gone to far.
He has been bombarded every day by email and phone calls, some late at night, accusing him of faking his results.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
